Can Mixed Fundamentals Have A Negative Impact on Sansure Biotech Inc. (SHSE:688289) Current Share Price Momentum?

Simply Wall StNov 18 00:08 ET

Does Sansure Biotech (SHSE:688289) Have A Healthy Balance Sheet?

Simply Wall StOct 27 23:57 ET

Sansure Biotech's Q3 Profit Plunges 81%

MT NewswiresOct 24 02:55 ET

Shengxiang Biology: Shengxiang Biotechnology Co., Ltd. Report for the Third Quarter of 2024

SZSIOct 23 12:00 ET · Announcements

Shengxiang Biotechnology Co., Ltd. Report for the Third Quarter of 2024

SZSIOct 23 12:00 ET · Announcements

sansure biotech inc. (688289.SH): The net income in the first three quarters was 0.195 billion yuan, a year-on-year decrease of 34.8%.

On October 23, Sansure Biotech Inc. (688289.SH) released its third-quarter report, with revenue of 1.03 billion yuan, a year-on-year increase of 63.24%; net income of 0.195 billion yuan, a year-on-year decrease of 34.8%; non-GAAP net income of 0.151 billion yuan, a year-on-year increase of 637.21%; basic earnings per share of 0.34 yuan.

Gelonghui FinanceOct 23 06:56 ET